-
Archives
- December 2017
- June 2017
- May 2017
- February 2017
- November 2016
- October 2016
- September 2016
- July 2016
- April 2016
- March 2016
- December 2015
- August 2015
- April 2015
- February 2015
- January 2015
- December 2014
- November 2014
- September 2014
- August 2014
- July 2014
- May 2014
- January 2014
- December 2013
- November 2013
- August 2013
- July 2013
- June 2013
- May 2013
- April 2013
- March 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- September 2012
- August 2012
- July 2012
- June 2012
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
-
Meta
Tag Archives: screening
A Second Look at the European Randomised Study OfScreening For Prostate Cancer
Last week, The Lancet published 13-year follow-up results from the European Randomised study of Screening for Prostate Cancer (ERSPC), an international trial of PSA testing in seven countries (the Netherlands, Belgium, Sweden, Finland, Italy, Spain, and Switzerland). (Unfortunately, the complete … Continue reading
Posted in Prostate Cancer
Tagged clinical trials, ERSPC, harms, PSA, screening
Comments Off on A Second Look at the European Randomised Study OfScreening For Prostate Cancer
With Prostate-Specific Antigen (PSA) Screening Questioned, Why Not Hurl Out the Next Unproven Prostate Tests?
The headline in the New York Times story this morning, “New Prostate Cancer Tests Could Reduce False Alarms,” by Andrew Pollack, had me scratching my head. Had I missed something in the story of advances in prostate cancer screening and … Continue reading
Posted in Prostate Cancer
Tagged false positives, Genomic Health, molecular markers, Myriad Genetics, PSA, screening, testing, treatment
Comments Off on With Prostate-Specific Antigen (PSA) Screening Questioned, Why Not Hurl Out the Next Unproven Prostate Tests?
Are Dense-Breast, Right-to-Know Laws Helpful?
In a victory for the dense-breast patient movement, Governor Jerry Brown (D-CA) signed legislation last week requiring that doctors who discover that women have dense breasts on mammography must inform women that: dense breasts are a risk factor for breast … Continue reading
Posted in breast cancer
Tagged imaging, mammography, MRI, right-to-know legislation, screening, women's health
2 Comments
Is the Bar High Enough for Screening Breast Ultrasounds for Dense Breasts?
In a unanimous decision yesterday, FDA approved the first breast ultrasound imaging system for dense breast tissue “for use in combination with a standard mammography in women with dense breast tissue who have a negative mammogram and no symptoms of … Continue reading
Posted in breast cancer, medical devices
Tagged dense breasts, FDA approval, mammography, screening
2 Comments
What’s Next for Prostate Cancer Screening and Treatment?
Complex medical stories require time and energy to tell, talk about, and think about. When stories involve yanking a test or practice that is widely used, all hell breaks lose. That’s why I am grateful to appear today on Alaska … Continue reading
Confused About What Health Reform Has to Offer: Sept. 23rd Marks One Year with New Patient Protections
You may not love every single bit of health reform coming down the pike, but make no mistake about it: new patient protections that went into effect one year ago had their one-year anniversary Sept. 23. I think health reform, … Continue reading
Writing About Alzheimer’s and Dementia Gets Complicated
Now that I have spent three days listening to expert neurologists, demographers, caregivers, and policy people talk about Alzheimer’s, I come away from the meeting with a sense that the story is complicated, and that I hope it is not … Continue reading
Posted in Alzheimer's disease
Tagged clinical trials, dementia, long term care, Medicare, patient protection, screening
6 Comments